Replies to post #360702 on Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

The stock is worth $50 minimum with Rett approval and nothing else. $2b to $5b in revenue in the U.S. alone. Apply a reasonable price-to-sales of say 5:1 and then do the math, using an assumed 100 million shares outstanding.

[FitzyP33]

My question is this: What are your comps for your statement? Or is just an opinion?

There is market for biotech CEOs so how does Missling's comp compare and/or how is it disproportionate?

Since I've been invested here Missling has been between $500 and $700K in salary with a 20% bonus (which he rarely if every earns in full). He also gets stock options that depending on a black scholes model are valued at ????. Ultimately, the options will be valued at a big number if the drug works and is brought to market and at ZERO if not. If ZERO Missling has made a good salary, but he is wagering a disproportionate amount of his total comp. on a big upside.

He took $1 million last year in options exercises, but that's all. Probably used the money for a down payment on a house or a 2nd home.

i do agree that the milestones for his current set of options are ridiculous, but the rest of elements of Missling's comp. it seems to me are not that egregious.

I haven't looked up comps. either and the board doesn't use a consultant to evaluate Missling's comp. (bad idea), but I don't see comp. as an issue. Just my opinion

You sound like Missling shouldn't get a dime which of course won't work for Missling unless he's independently wealthy.